Puyod, Agripino B.

HRN: 27-22-65  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2025
CEFTAZIDIME 1GM (VIAL)
06/06/2025
06/13/2025
IV
1gram
Q8h
CAP HR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: